{"id":"CHEMBL1084430","canonicalSmiles":"CO[C@@H]1[C@H](OP(=O)(S)OC[C@H]2O[C@@H](n3cnc4c(N)ncnc43)C[C@@H]2O)[C@@H](CO)O[C@H]1n1ccc(=O)[nH]c1=O","inchiKey":"LYMICVBGNUEHGE-FUQPUAIBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"INARIGIVIR","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Inarigivir","ORI-9020","SB-40"],"crossReferences":{"drugbank":["DB15062"]},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL110674","canonicalSmiles":"CC[C@H](C(=O)N1CCCC[C@H]1C(=O)O[C@H](CCc1ccc(OC)c(OC)c1)c1cccc(OCC(=O)O)c1)c1cc(OC)c(OC)c(OC)c1","inchiKey":"XCCRAOPQCACRFC-OIFRRMEBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL110674","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01723"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL116","canonicalSmiles":"CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CCOC1)S(=O)(=O)c1ccc(N)cc1","inchiKey":"YMARZQAQMVYCKC-OEMFJLHTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMPRENAVIR","yearOfFirstApproval":1999,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Agenerase"],"synonyms":["141 W94","141W94","Agenerase","Amprenavir","J05AE05","KVX-478","VX-478"],"crossReferences":{"Wikipedia":["Amprenavir"],"drugbank":["DB00701"],"chEBI":["40050"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1999 and is indicated for viral disease and has 2 investigational indications."}
{"id":"CHEMBL1200379","canonicalSmiles":"Cl.Nc1cc(Cl)c(N=C2NCCN2)c(Cl)c1","inchiKey":"OTQYGBJVDRBCHC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"APRACLONIDINE HYDROCHLORIDE","yearOfFirstApproval":1987,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL647","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Apraclonidine hydrochloride","Iopidine"],"synonyms":["AL-02145","AL02145","Aplonidine hydrochloride","Apraclonidine hcl","Apraclonidine hydrochloride"],"crossReferences":{"DailyMed":["apraclonidine%20hydrochloride"],"PubChem":["144204758","50105753"],"chEBI":["2789"]},"linkedTargets":{"rows":["ENSG00000184160","ENSG00000274286","ENSG00000150594"],"count":3},"linkedDiseases":{"rows":["EFO_0007167"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1987."}
{"id":"CHEMBL1200593","drugType":"Small molecule","blackBoxWarning":true,"name":"GADOTERIDOL","yearOfFirstApproval":1992,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Prohance","Prohance multipack"],"synonyms":["Gadoteridol","NSC-760055","SQ 32,692","SQ-32692"],"crossReferences":{"DailyMed":["gadoteridol"],"DrugCentral":["1268"],"PubChem":["144206576","144206679","170466854"],"Wikipedia":["Gadoteridol"],"chEBI":["31643"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1992. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200989","canonicalSmiles":"CCC(=O)OCC(=O)[C@@]1(OC(=O)CC)[C@H](C)C[C@H]2[C@H]3[C@H]([C@@H](O)C[C@@]21C)[C@@]1(C)C=CC(=O)C=C1C[C@H]3Cl","inchiKey":"DJHCCTTVDRAMEH-DUUJBDRPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALCLOMETASONE DIPROPIONATE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aclovate","Alclometasone dipropionate","Modrasone"],"synonyms":["Alclometasone","Alclometasone 17,21-dipropionate","Alclometasone dipropionate","NSC-758914","SCH 22219","SCH-22219"],"crossReferences":{"DailyMed":["alclometasone%20dipropionate"],"PubChem":["144204277"],"chEBI":["31184"]},"linkedTargets":{"rows":["ENSG00000113580"],"count":1},"linkedDiseases":{"rows":["EFO_0000701","EFO_0003060","EFO_0005752"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1982 and is indicated for skin disease and eye inflammation and has 1 investigational indication."}
{"id":"CHEMBL1201203","canonicalSmiles":"CN1[C@H]2CC[C@@H]1C[C@H](OC(c1ccccc1)c1ccccc1)C2","inchiKey":"GIJXKZJWITVLHI-PMOLBWCYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BENZTROPINE","yearOfFirstApproval":1954,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Benzatropine","Benztropine","Cobrentin","NK-02"],"crossReferences":{"DailyMed":["benztropine%20mesylate"],"PubChem":["144204856","144205248","29215426"],"Wikipedia":["Benzatropine"],"drugbank":["DB00245"],"chEBI":["3048"]},"childChemblIds":["CHEMBL1200383"],"linkedTargets":{"rows":["ENSG00000168539"],"count":1},"linkedDiseases":{"rows":["MONDO_0005090","EFO_0002610","MONDO_0005180","EFO_0009387","EFO_0005279","HP_0003418","HP_0011868","HP_0000713"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1954 and is indicated for parkinson disease and has 5 investigational indications."}
{"id":"CHEMBL1201572","drugType":"Protein","blackBoxWarning":true,"name":"ETANERCEPT","yearOfFirstApproval":1998,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Benepali","Enbrel"],"synonyms":["Chs-0214","Davictrel","Dwp-422","Enia-11","Erelzi","Etanercept","Etanercept (enbrel)","Etanercept biosimilar (gp-2015)","Etanercept biosimilar (sb-4)","Etanercept-szzs","Etanercept-ykro","Eticovo","GP-2015","GP2015","GP2015C","HD203","Hd-203","L04ab01","LBEC0101","Lbec-0101","RHU TNFR:FC","RHU-TNFR:FC","TNFR-IMMUNOADHESIN","Tunex"],"crossReferences":{"DailyMed":["etanercept"],"DrugCentral":["4978"],"Wikipedia":["Etanercept"]},"linkedTargets":{"rows":["ENSG00000232810"],"count":1},"linkedDiseases":{"rows":["EFO_1000710","EFO_0004274","EFO_0007323","MONDO_0002959","EFO_0000540","HP_0011868","EFO_0008997","EFO_0000565","EFO_0003884","EFO_0000676","EFO_0004208","EFO_0004276","EFO_0004719","EFO_0000198","MONDO_0013730","HP_0000360","EFO_0005761","EFO_0002687","HP_0002039","MONDO_0008315","EFO_0009448","MP_0001845","EFO_0007430","MONDO_0003937","EFO_0000398","EFO_0009688","HP_0004326","MONDO_0004979","EFO_0000341","Orphanet_314701","EFO_0000699","Orphanet_84","EFO_1001494","EFO_0003778","EFO_0004246","EFO_0008518","EFO_0005531","EFO_0005279","EFO_1000726","EFO_0000616","EFO_0000685","EFO_0003898","MONDO_0019558","EFO_0004599","EFO_0002609","EFO_0003106","EFO_0000195","EFO_0003834","EFO_0000713","EFO_0000095","EFO_0005297","MONDO_0005147","EFO_0000764","MONDO_0004975","EFO_0000706","EFO_0000612","HP_0100727","MONDO_0024280"],"count":58},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1998 and has 8 approved and 46 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1229525","canonicalSmiles":"Cn1cc(-c2cc3cccnc3[nH]2)c2cc(C(=O)NC(C)(C)CO)ccc21","inchiKey":"XZRYCTLOGNCQDG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1229525","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06834"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1230982","canonicalSmiles":"c1cncc(C2=NCCCC2)c1","inchiKey":"AUBPMADJYNSPOA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ANABASEINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Anabaseine"],"crossReferences":{"chEBI":["80787"]},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL1231206","canonicalSmiles":"Cc1ccc(-c2ccc3c(ccc4sc5c(c43)NC[C@@H](C)NC5=O)n2)cn1","inchiKey":"CMWRPDHVGMHLSZ-GFCCVEGCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1231206","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07430"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1231396","canonicalSmiles":"CCCC(N)=O","inchiKey":"DNSISZSEWVHGLH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BUTYRAMIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02121"],"chEBI":["50724"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1233528","canonicalSmiles":"CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)N[C@H]4CC[C@H](N5CCN(CC6CC6)CC5)CC4)cc3OC)nc2N1C(C)C","inchiKey":"SXNJFOWDRLKDSF-STROYTFGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VOLASERTIB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BI 6727","BI-6727","Bi-6727","Volasertib"],"crossReferences":{"drugbank":["DB12062"]},"childChemblIds":["CHEMBL2105742"],"linkedTargets":{"rows":["ENSG00000166851"],"count":1},"linkedDiseases":{"rows":["EFO_0000198","EFO_0000616","EFO_1001257","EFO_0000565","EFO_0000221","EFO_0003893","EFO_0002913","EFO_0000574","EFO_0000222","MONDO_0003541","EFO_0003060","MONDO_0000430"],"count":12},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 11 investigational indications."}
{"id":"CHEMBL1234222","canonicalSmiles":"OC[C@H]1O[C@@H](O)[C@@H](F)[C@@H](O)[C@@H]1O","inchiKey":"ZCXUVYAZINUVJD-AIECOIEWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1234222","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04483"],"chEBI":["49152"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1234370","canonicalSmiles":"COc1ccc(S(=O)(=O)N2CCCSC(C)(C)[C@H]2C(=O)NO)cc1","inchiKey":"CYYCSKFJEOSZTF-CYBMUJFWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1234370","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02350"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL123558","canonicalSmiles":"CN1CCN(CCCCN2C(=O)CN(/N=C/c3ccc(-c4ccc(Cl)cc4)o3)C2=O)CC1","inchiKey":"MREBEPTUUMTTIA-PCLIKHOPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZIMILIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Azimilide"],"crossReferences":{"Wikipedia":["Azimilide"],"chEBI":["34545"]},"childChemblIds":["CHEMBL3140370","CHEMBL537847"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL1237022","drugType":"Antibody","blackBoxWarning":true,"name":"TOCILIZUMAB","yearOfFirstApproval":2005,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Actemra","Actemra roactemra","Roactemra"],"synonyms":["ATLIZUMAB","Actemra","BAT-1806","BAT1806","Bat1806","MRA","MSB-11456","MSB11456","R-1569","RG-1569","RHPM-1","RO-4877533","Tocilizumab"],"crossReferences":{"DailyMed":["tocilizumab"],"DrugCentral":["4933"],"Wikipedia":["Tocilizumab"]},"linkedTargets":{"rows":["ENSG00000160712"],"count":1},"linkedDiseases":{"rows":["EFO_0001361","MONDO_0002009","EFO_0003780","EFO_0000756","EFO_0005952","EFO_0000540","EFO_1001148","EFO_1001951","EFO_0000565","EFO_0007135","EFO_0000096","EFO_0002690","EFO_0000182","EFO_0003884","EFO_0008528","MONDO_0015540","EFO_0007541","EFO_1000789","MONDO_0004976","EFO_0000094","EFO_0004991","EFO_0009730","MONDO_0013730","EFO_0002618","EFO_0009686","EFO_1001857","EFO_0003782","EFO_1000069","EFO_0000220","MONDO_0008170","EFO_1001466","EFO_1001806","MONDO_0018848","Orphanet_249","MONDO_0044881","EFO_1001119","EFO_1001209","EFO_1001231","EFO_1000986","MONDO_0100096","EFO_0000398","EFO_0004256","EFO_0000574","EFO_0007328","EFO_0001378","MONDO_0015564","MONDO_0005090","MONDO_0007254","EFO_1000926","EFO_1001165","EFO_1000637","EFO_1001513","MONDO_0001187","EFO_0008518","EFO_1000044","EFO_1001801","EFO_0000673","EFO_0009321","Orphanet_342","EFO_0000717","EFO_0008586","EFO_0000616","EFO_0000694","EFO_0000685","EFO_0000478","HP_0001945","EFO_0003898","EFO_0000403","EFO_0000222","EFO_0003818","EFO_0004599","EFO_0003060","EFO_0002609","EFO_0003106","EFO_1001999","EFO_0000095","EFO_0000764","MONDO_0005147","MONDO_0018906","EFO_0005411","EFO_0000519"],"count":81},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2005 and has 5 approved and 60 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL126224","canonicalSmiles":"CN(C)CCCn1c2c(c3ccccc31)CCCCCC2","inchiKey":"PLIGPBGDXASWPX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IPRINDOLE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Galatur","Iprindole","NSC-169449","Pramindole","Prondol","Tertran","WY-3263"],"crossReferences":{"Wikipedia":["Iprindole"],"drugbank":["DB13496"]},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for unipolar depression."}
{"id":"CHEMBL1315492","canonicalSmiles":"C=CC[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3C=C[C@@]21C","inchiKey":"VWAUPFMBXBWEQY-ANULTFPQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALTRENOGEST","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Regu-mate"],"synonyms":["A-35957","Allyltrenbolone","Altrenogest","NSC-759180","RU-2267"],"crossReferences":{"PubChem":["144206907","170465646","29218067"],"drugbank":["DB11372"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1437764","canonicalSmiles":"CC(C)(C)C(=O)C(Oc1ccc(Cl)cc1)n1ccnc1","inchiKey":"OWEGWHBOCFMBLP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CLIMBAZOLE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BAY-E 6975","Baypival","Climbazole","Crinipan ad","NSC-759808"],"crossReferences":{"PubChem":["144205896","170465557","29217911"],"drugbank":["DB15580"],"chEBI":["83719"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1440","canonicalSmiles":"CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12","inchiKey":"OFVLGDICTFRJMM-WESIUVDSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TETRACYCLINE","yearOfFirstApproval":2006,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"]},"tradeNames":["Achromycin","Achromycin v","Cyclopar","Economycin","Liquamycin","Panmycin","Supramycin","Sustamycin","Tetrabid organon","Tetracyn","Vetquamycin"],"synonyms":["E701","NSC-108579","Tetracycline"],"crossReferences":{"DailyMed":["tetracycline%20hydrochloride"],"PubChem":["144210470"],"TG-GATEs":["48"],"Wikipedia":["Tetracycline"],"drugbank":["DB00759"],"chEBI":["27902"]},"childChemblIds":["CHEMBL454950","CHEMBL1201071"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2006 and has 9 approved and 12 investigational indications. It was withdrawn in United States."}
{"id":"CHEMBL1451","canonicalSmiles":"C[C@]12C[C@H](O)[C@@]3(F)[C@@H](CCC4=CC(=O)C=C[C@@]43C)[C@@H]1C[C@@H](O)[C@]2(O)C(=O)CO","inchiKey":"GFNANZIMVAIWHM-OBYCQNJPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRIAMCINOLONE","yearOfFirstApproval":1957,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aristocort","Aristocort A","Delphicort","Kenacort","Kenalog","Triamcinolone","Volon"],"synonyms":["Fluoxiprednisolone","NSC-13397","Triamcinolone"],"crossReferences":{"PubChem":["144204885","144210498","170465188","26751455","47193900","50103941","50103942","77851","855586","90341396"],"Wikipedia":["Triamcinolone"],"drugbank":["DB00620"],"chEBI":["9667"]},"linkedTargets":{"rows":["ENSG00000113580"],"count":1},"linkedDiseases":{"rows":["EFO_0004683","EFO_0010822","EFO_0007486","EFO_1000710","EFO_0000756","EFO_1000809","MONDO_0002959","HP_0002043","EFO_1000786","EFO_0000676","EFO_0004616","HP_0003419","EFO_0004208","EFO_0009552","EFO_0008517","EFO_0003940","EFO_1001250","EFO_0005854","HP_0012532","EFO_1001466","EFO_0000701","HP_0001742","HP_0002027","MP_0001845","EFO_0009260","HP_0006536","EFO_0004192","EFO_1000391","HP_0030833","EFO_0000341","EFO_0000342","MONDO_0003005","EFO_1001896","EFO_0001365","EFO_1000879","EFO_0008507","EFO_0003778","EFO_0000274","HP_0030834","EFO_0004212","EFO_0009321","EFO_1001417","EFO_0005752","EFO_0009625","EFO_1002005","EFO_0000685","EFO_0003963","EFO_0003898","EFO_1001157","EFO_0003770","EFO_0001073","EFO_0003843","HP_0002315","EFO_0010582","MONDO_0005178","EFO_1000662","EFO_0004264"],"count":57},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1957 and has 5 approved and 29 investigational indications."}
{"id":"CHEMBL1516474","canonicalSmiles":"CCCCCNC(=N)N/N=C/c1c[nH]c2ccc(OC)cc12.O=C(O)/C=C\\C(=O)O","inchiKey":"CPDDZSSEAVLMRY-FEQFWAPWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TEGASEROD MALEATE","yearOfFirstApproval":2002,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL76370","hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"],"classes":["Cardiotoxicity"," Neurotoxicity"],"year":2007},"tradeNames":["Zelmac","Zelnorm"],"synonyms":["HTF 919","HTF-919","NSC-760425","Tegaserod maleate"],"crossReferences":{"DailyMed":["tegaserod%20maleate"],"PubChem":["26748994"],"chEBI":["51044"]},"linkedTargets":{"rows":["ENSG00000164270"],"count":1},"linkedDiseases":{"rows":["EFO_0000555","MONDO_0002203"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2002 and is indicated for irritable bowel syndrome and constipation disorder. It was withdrawn in United States  in 2007 due to Cardiotoxicity and  Neurotoxicity."}
{"id":"CHEMBL1571","canonicalSmiles":"C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)C=C[C@@]43C)[C@@H]1CCC(=O)O2","inchiKey":"BPEWUONYVDABNZ-DZBHQSCQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TESTOLACTONE","yearOfFirstApproval":1969,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Fludestrin","Teslac"],"synonyms":["NSC-23759","SQ 9538","SQ-9538","Teolit","Testolactone","Testolactone ciii"],"crossReferences":{"PubChem":["144205129","85554"],"Wikipedia":["Testolactone"],"drugbank":["DB00894"],"chEBI":["9460"]},"linkedTargets":{"rows":["ENSG00000137869"],"count":1},"linkedDiseases":{"rows":["MONDO_0000088"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1969 and has 1 investigational indication."}
{"id":"CHEMBL1574","canonicalSmiles":"CC(C)(N)Cc1ccccc1","inchiKey":"DHHVAGZRUROJKS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHENTERMINE","yearOfFirstApproval":1959,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Duromine","Ionamin","Phentermine resin 30","Phentermine resin complex"],"synonyms":["NSC-759163","Phentermine","Phentermine resin","Phentermine resin complex","Qsiva"],"crossReferences":{"DailyMed":["phentermine%20hydrochloride"],"Wikipedia":["Phentermine"],"drugbank":["DB00191"],"chEBI":["8080"]},"childChemblIds":["CHEMBL1200912"],"linkedTargets":{"rows":["ENSG00000103546"],"count":1},"linkedDiseases":{"rows":["EFO_0005204","EFO_0003086","EFO_0003890","EFO_0001074","EFO_0003144","EFO_0001421","EFO_0010445","EFO_0001073","EFO_0000400"],"count":9},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1959 and is indicated for obesity and has 6 investigational indications."}
{"id":"CHEMBL15841","canonicalSmiles":"CCOC(=O)c1ccc(O)cc1","inchiKey":"NUVBSKCKDOMJSU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETHYLPARABEN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Aseptoform e","E-214","E214","Ethyl hydroxybenzoate","Ethyl p-hydroxybenzoate","Ethyl p-oxybenzoate","Ethyl paraben","Ethyl parahydroxybenzoate","Ethyl parahydroxybenzoate e214","Ethyl-p-hydroxybenzoate","Ethylis hydroxybenzoas","Ethylparaben","Ins no.214","Ins-214","NSC-23514","Tegosept e"],"crossReferences":{"PubChem":["144205514","144210653","170465715","26754637","74198"],"Wikipedia":["Ethylparaben"],"drugbank":["DB13628"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1591074","canonicalSmiles":"c1ccc2sc(SNC3CCCCC3)nc2c1","inchiKey":"DEQZTKGFXNUBJL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1591074","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144205274","144209634","144213241","29215471"],"drugbank":["DB14200"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1697767","canonicalSmiles":"OC(CNc1ccccn1)c1ccccc1","inchiKey":"ZEAJXCPGHPJVNP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHENYRAMIDOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cabral","Evasprin","Fenyramidol","MJ-505","NSC-23634"],"crossReferences":{"Wikipedia":["Fenyramidol"],"drugbank":["DB13414"]},"childChemblIds":["CHEMBL1996759"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1743070","drugType":"Antibody","blackBoxWarning":false,"name":"SILTUXIMAB","yearOfFirstApproval":2014,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Sylvant"],"synonyms":["CLLB8","CNTO-328","Siltuximab"],"crossReferences":{"DailyMed":["siltuximab"],"DrugCentral":["4977"]},"linkedTargets":{"rows":["ENSG00000136244"],"count":1},"linkedDiseases":{"rows":["EFO_0000198","MONDO_0005090","EFO_0000681","EFO_0000540","MONDO_0008315","EFO_0001663","EFO_1001332","EFO_0000203","EFO_1000044","MONDO_0100096","MONDO_0005147","EFO_0000673","MONDO_0002367","EFO_0001378","MONDO_0015564"],"count":15},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2014 and has 3 approved and 11 investigational indications."}
{"id":"CHEMBL17976","canonicalSmiles":"C=C(C)[C@]12C[C@@H](C)[C@@]34O[C@](Cc5ccccc5)(O[C@@H]1[C@@H]3C=C(COC(=O)Cc1ccc(O)c(OC)c1)C[C@]1(O)C(=O)C(C)=C[C@H]14)O2","inchiKey":"DSDNAKHZNJAGHN-MXTYGGKSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RESINIFERATOXIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Neuroclastin"],"synonyms":["Lopain","MTX-71","Mtx-071","RTX","Resiniferatoxin"],"crossReferences":{"PubChem":["26755740"],"drugbank":["DB06515"]},"linkedTargets":{"rows":["ENSG00000196689"],"count":1},"linkedDiseases":{"rows":["EFO_0003843","EFO_0000311"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL186720","canonicalSmiles":"CN(C)CCOc1ccccc1Cc1ccccc1","inchiKey":"IZRPKIZLIFYYKR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHENYLTOLOXAMINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Phenyltoloxamine","Phenyltoloxamine resin complex"],"crossReferences":{"PubChem":["104171393","50103870","50104019"],"Wikipedia":["Phenyltoloxamine"],"drugbank":["DB11160"]},"childChemblIds":["CHEMBL3925724","CHEMBL544235","CHEMBL1586457"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1873475","canonicalSmiles":"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1","inchiKey":"XYFPWWZEPKGCCK-GOSISDBHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IBRUTINIB","yearOfFirstApproval":2013,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Imbruvica"],"synonyms":["CRA-032765","Ibrutinib","PC-32765","PCI 32765","PCI-32765","PCI-32765-00"],"crossReferences":{"DailyMed":["ibrutinib"],"PubChem":["124898784"],"drugbank":["DB09053"],"chEBI":["76612"]},"linkedTargets":{"rows":["ENSG00000010671"],"count":1},"linkedDiseases":{"rows":["MONDO_0009348","EFO_0000681","MONDO_0044887","MONDO_0007254","EFO_1001469","EFO_1001264","EFO_0005952","MONDO_0021063","EFO_1001951","EFO_0000565","EFO_0000309","EFO_1000044","EFO_1001935","EFO_0000096","EFO_1000956","EFO_0000389","MONDO_0008903","EFO_0004289","EFO_1000630","MONDO_0004111","MONDO_0100053","EFO_0000183","MONDO_0002083","EFO_0002617","EFO_0009441","MONDO_0013730","EFO_0000616","EFO_0000198","EFO_0000220","EFO_0002616","EFO_0000403","EFO_1000157","EFO_0000222","EFO_1001875","MONDO_0007576","EFO_0004243","MONDO_0017596","MONDO_0044881","EFO_0003060","MONDO_0008315","EFO_0000311","MONDO_0100096","MONDO_0001023","EFO_0000095","EFO_0007359","EFO_0001421","EFO_0000574","EFO_1001890","EFO_1000560","MONDO_0018906","EFO_0001378","EFO_0000181","EFO_0000519"],"count":53},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2013 and has 4 approved and 41 investigational indications."}
{"id":"CHEMBL1923502","canonicalSmiles":"C[C@@H]1CN[C@@H](C2CC2)C(=O)N(C)[C@H](C)C(=O)N[C@H](Cc2ccc(F)cc2)C(=O)NCCCc2ccccc2O1.Cl.O","inchiKey":"ZWIXEQBDJMFCMN-DHHNQDMHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ULIMORELIN HYDROCHLORIDE","maximumClinicalTrialPhase":3,"parentId":"CHEMBL1963249","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["TZP-101","Ulimorelin hydrochloride","Ulimorelin hydrochloride monohydrate"],"linkedTargets":{"rows":["ENSG00000121853"],"count":1},"linkedDiseases":{"rows":["MONDO_0004567","EFO_1000948"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1951706","canonicalSmiles":"CN1CC[C@]23c4c5ccc(O)c4O[C@H]2[C@@H](O)CC[C@@]3(O)[C@H]1C5","inchiKey":"AABLHGPVOULICI-BRJGLHKUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HYDROMORPHINOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[".alpha.-oxymorphol","14-hydroxy-7,8-dihydromorphine","14-hydroxydihydromorphine","6.alpha.-oxymorphol","Hydromorphinol","IDS-NH-003","Numorphan oral"],"crossReferences":{"drugbank":["DB01512"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1987462","canonicalSmiles":"CCCCNCC(O)c1ccc(O)cc1","inchiKey":"RDUHXGIIUDVSHR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BAMETHAN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Bamethan","Vasolat"],"crossReferences":{"PubChem":["29216104"],"drugbank":["DB13206"]},"childChemblIds":["CHEMBL2106636"],"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL2079793","canonicalSmiles":"Nc1nc([O-])c2ncn(CCC(CO)CO)c2n1.[Na+]","inchiKey":"NMQFQBOIHUIALG-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"PENCICLOVIR SODIUM","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":0,"parentId":"CHEMBL1540","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Denavir"],"synonyms":["BRL-39123-D","Penciclovir sodium","Sodium penciclovir"],"description":"Small molecule drug with a maximum clinical trial phase of I that was first approved in 1996."}
{"id":"CHEMBL2104340","canonicalSmiles":"Nc1nc(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1I","inchiKey":"WEVJJMPVVFNAHZ-RRKCRQDMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IBACITABINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ibacitabine","NSC-527083"],"crossReferences":{"drugbank":["DB13776"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2104967","canonicalSmiles":"CCOCc1cc(OC)c(-c2ccc(C[C@H](NC(=O)c3c(F)cccc3F)C(=O)O)cc2)c(OC)c1","inchiKey":"YLFZHHDVRSYTKT-NRFANRHFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FIRATEGRAST","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Firategrast","SB-683699"],"crossReferences":{"drugbank":["DB12732"]},"linkedTargets":{"rows":["ENSG00000150093","ENSG00000115232","ENSG00000139626"],"count":3},"linkedDiseases":{"rows":["MONDO_0005301","EFO_0003929"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2105224","canonicalSmiles":"CN1CC[C@]23c4c5ccc(OCCN6CCOCC6)c4O[C@H]2[C@@H](O)C=C[C@H]3[C@H]1C5","inchiKey":"GPFAJKDEDBRFOS-FKQDBXSBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHOLCODINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dia-tuss","Ethnine simplex","Evaphol","Evaphol strong","Galenphol","Gppe linct","Pavacol-d","Pholcomed fte","Sancos co","Tixylix daytime","Tixylix dry cough","Tixylix night cough","Tixylix night-time"],"synonyms":["Biocalyptol","Codylin","DEA NO. 9314","Ethnine","Folcodine","Glycodine","Hibernyl","Homocodeine","Memine","Morpholinylethylmorphine","Neocodine","Pholcodine","Pholcodine monohydrate","Pholtex","Tussokon","Weifacodine"],"crossReferences":{"drugbank":["DB09209"],"chEBI":["53579"]},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for cough."}
{"id":"CHEMBL2105639","canonicalSmiles":"CC[C@H](C)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)CC(=O)O)C(C)C)C(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)O)[C@@H](C)O)[C@@H](C)O)C(C)C","inchiKey":"RCTCWZRPYFBGLQ-KVBIMOIYSA-N","drugType":"Protein","blackBoxWarning":false,"name":"DIRUCOTIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dirucotide","MBP-8298","MBP8298","SF328"],"childChemblIds":["CHEMBL2105640"],"description":"Protein drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2105667","canonicalSmiles":"Cc1cc(F)ccc1[C@H]1C[C@@H](N2CCN3C(=O)CC[C@H]3C2)CCN1C(=O)N(C)[C@H](C)c1cc(C(F)(F)F)cc(C(F)(F)F)c1","inchiKey":"XWNBGDJPEXZSQM-VZOBGQTKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ORVEPITANT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GW-823296X","GW823296X","Gw-823296","Gw823296","Orvepitant"],"crossReferences":{"drugbank":["DB12427"]},"childChemblIds":["CHEMBL2105668"],"linkedTargets":{"rows":["ENSG00000115353"],"count":1},"linkedDiseases":{"rows":["MONDO_0002050","MONDO_0002009","HP_0012735","EFO_0001358"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL2107341","canonicalSmiles":"OCCOCCOc1ccc(/C(=C(/CCCl)c2ccccc2)c2ccccc2)cc1","inchiKey":"NKZTZAQIKKGTDB-QPLCGJKRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FISPEMIFENE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fispemifene","HM-101","HM-101a"],"crossReferences":{"drugbank":["DB06640"]},"linkedTargets":{"rows":["ENSG00000091831","ENSG00000140009"],"count":2},"linkedDiseases":{"rows":["MONDO_0002146","EFO_0004714","EFO_0004234","MONDO_0018555"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL2107372","canonicalSmiles":"CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@@]1(C)C(=O)[C@H](OC(=O)C3CCCC3)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)C)c4cccs4)C[C@@](O)([C@@H](OC(=O)c4ccccc4)[C@@H]12)C3(C)C","inchiKey":"SLGIWUWTSWJBQE-VLCCYYTCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SIMOTAXEL","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MST-997","Simotaxel"],"crossReferences":{"drugbank":["DB15384"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2107381","canonicalSmiles":"CC(=O)OC[C@H]1O[C@@H](n2ccc(=O)[nH]c2=O)[C@H](OC(C)=O)[C@@H]1OC(C)=O","inchiKey":"AUFUWRKPQLGTGF-FMKGYKFTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"URIDINE TRIACETATE","yearOfFirstApproval":2015,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Vistogard","Xuriden"],"synonyms":["PN-401","PN401","RG-2133","RG2133","Uridine triacetate","Vistonuridine"],"crossReferences":{"DailyMed":["uridine%20triacetate"],"drugbank":["DB09144"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2015 and has 5 investigational indications."}
{"id":"CHEMBL2107531","canonicalSmiles":"CC(SC(=O)c1cccs1)C(=O)NCC(=O)O","inchiKey":"JNYSEDHQJCOWQU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"STEPRONIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bronco-plus","Prostenoglycine","Stepronin","Tiase","Tiofacic"],"crossReferences":{"drugbank":["DB01423"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2107726","canonicalSmiles":"[O-][n+]1cccc(/C(Cl)=N/OC[C@H](O)CN2CCCCC2)c1","inchiKey":"SGEIEGAXKLMUIZ-XUVDNFPMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ARIMOCLOMOL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Arimoclomol","BRX-220 FREE BASE"],"childChemblIds":["CHEMBL4298149"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL2108469","drugType":"Protein","blackBoxWarning":false,"name":"MUPLESTIM","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Hemokine"],"synonyms":["Il-3 (non-glycosylated)","Interleukin-3","Interleukin-3 (non-glycosylated)","Interleukin-3 muplestim","Muplestim","Rgii complex tm","SDZ ILE 964","SDZ-ILE-964","Sh-polypeptide-29"],"description":"Protein drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2108741","drugType":"Unknown","blackBoxWarning":false,"name":"SIMETICONE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Asilone windcheaters","Infacol","Phazyme","Wind-eze","Windsetlers"],"synonyms":["Simeticone"],"description":"Unknown drug with a maximum clinical trial phase of IV and has 1 investigational indication."}
{"id":"CHEMBL2108752","drugType":"Unknown","blackBoxWarning":false,"name":"PEGAPTANIB OCTASODIUM","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pegaptanib","Pegaptanib octasodium"],"crossReferences":{"DrugCentral":["4905"]},"linkedTargets":{"rows":["ENSG00000112715"],"count":1},"linkedDiseases":{"rows":["EFO_0004683","EFO_0005753"],"count":2},"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2108766","drugType":"Unknown","blackBoxWarning":false,"name":"PYRETHRUM EXTRACT","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pyrethrum","Pyrethrum extract"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2108930","drugType":"Unknown","blackBoxWarning":false,"name":"CRANBERRY LIQUID PREPARATION","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cranberry liquid preparation"],"description":"Unknown drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2109084","drugType":"Enzyme","blackBoxWarning":false,"name":"DESMOTEPLASE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Desmoteplase","Dspa desmoteplase","RDSPA ALPHA 1"],"linkedTargets":{"rows":["ENSG00000122194"],"count":1},"linkedDiseases":{"rows":["HP_0002140","EFO_0000712"],"count":2},"description":"Enzyme drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2109162","drugType":"Small molecule","blackBoxWarning":false,"name":"HEMOGLOBIN GLUTAMER","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Hemoglobin glutamer","Hemoglobin glutamer (bovine)"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2109205","drugType":"Protein","blackBoxWarning":false,"name":"NONACOG ALFA","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Benefix"],"synonyms":["Nonacog alfa","Nonacog gamma"],"crossReferences":{"DrugCentral":["5163"]},"description":"Protein drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2109390","drugType":"Antibody","blackBoxWarning":false,"name":"MAB-425","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MAB-425","Mab-425"],"linkedTargets":{"rows":["ENSG00000146648"],"count":1},"linkedDiseases":{"rows":["EFO_0000326"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2109399","drugType":"Antibody","blackBoxWarning":false,"name":"T-DM1","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["T-DM1"],"linkedTargets":{"rows":["ENSG00000141736"],"count":1},"linkedDiseases":{"rows":["MONDO_0007254"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2109449","drugType":"Antibody","blackBoxWarning":false,"name":"MEDI-570","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MEDI-570","Medi 570","Medi-570"],"linkedTargets":{"rows":["ENSG00000163600"],"count":1},"linkedDiseases":{"rows":["EFO_0002690"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL213758","canonicalSmiles":"O=C(O)COc1c(C(=O)O)sc(-c2ccccc2)c1Br","inchiKey":"MVDWLRCTJUXCCB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL213758","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07130"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2146123","canonicalSmiles":"C=C1c2cccc(O)c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@H]12.Cl","inchiKey":"VZQARNDJLLWXGL-CCHMMTNSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHACYCLINE HYDROCHLORIDE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL249837","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Rondomycin"],"synonyms":["Metacycline hydrochloride","Methacycline hcl","Methacycline hydrochloride","NSC-356465","NSC-757835"],"crossReferences":{"PubChem":["144204093","170465224"],"chEBI":["6806"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982 and has 1 investigational indication."}
{"id":"CHEMBL2146146","canonicalSmiles":"CN1[C@H]2CC[C@@H]1C[C@H](OC(=O)C(CO)c1ccccc1)C2.O=S(=O)(O)O","inchiKey":"VJFQPODMEGSXHC-RIMUKSHESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ATROPINE SULFATE","yearOfFirstApproval":1960,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL517712","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Atropine","Atropine sulfate","Atropine sulfate ansyr plastic syringe","Atropine sulfate lifeshield abboject syringe","Isopto atropine"],"synonyms":["Atropine sulfate","Atropine sulfate anhydrous","Atropine sulfate hydrate","Atropine sulfate monohydrate","Atropine sulphate","Atropini sulfas","Atropinum sulphuricum","Atropt","NSC-26671","NSC-755889"],"crossReferences":{"DailyMed":["atropine%20sulfate"]},"linkedTargets":{"rows":["ENSG00000133019","ENSG00000181072","ENSG00000168539"],"count":3},"linkedDiseases":{"rows":["EFO_0005854","HP_0004398","EFO_0000304","EFO_0005758","EFO_0005323","MONDO_0005180","HP_0000545","EFO_0010581","HP_0011499","HP_0002315","EFO_0003956"],"count":11},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1960 and has 5 approved and 3 investigational indications."}
{"id":"CHEMBL2163631","canonicalSmiles":"COc1cc(C(=O)c2c[nH]c(-c3c[nH]c4ccccc34)n2)cc(OC)c1OC","inchiKey":"WQGVHOVEXMOLOK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SABIZABULIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Sabizabulin","VERU-111","Veru-111"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL21869","canonicalSmiles":"O=C(Nc1ccc(Br)cc1)c1cc(Br)ccc1O","inchiKey":"CTFFKFYWSOSIAA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIBROMSALAN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"]},"tradeNames":[],"synonyms":["Dibromsalan","NSC-20527"],"description":"Small molecule drug with a maximum clinical trial phase of IV. It was withdrawn in United States."}
{"id":"CHEMBL219484","canonicalSmiles":"N=C(N)NC(=N)Nc1cc(C(F)(F)F)ccc1Cl","inchiKey":"IGFTZEOFHWPCDL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL219484","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08478"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL222645","canonicalSmiles":"Cc1onc(-c2c(F)cccc2Cl)c1C(=O)N[C@@H]1C(=O)N2[C@@H](C(=O)O)C(C)(C)S[C@H]12","inchiKey":"UIOFUWFRIANQPC-JKIFEVAISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLOXACILLIN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Abboflox","Floxapen","Fluclomix-250","Fluclomix-500","Flucloxin","Galfloxin","Ladropen","Rimaflox","Stafoxil","Staphlipen","Zoxin 250","Zoxin 500"],"synonyms":["BRL 2039","BRL-2039","Culpen","Floxacillin","Floxacillin sodium","Floxacillin sodium anhydrous","Flucloxacillin","Flucloxacillin sodium","Flucloxacillin sodium anhydrous","NSC-277175","Staphylex"],"crossReferences":{"Wikipedia":["Flucloxacillin"],"drugbank":["DB00301"],"chEBI":["5098"]},"childChemblIds":["CHEMBL3187256","CHEMBL283053"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for bacterial disease and has 5 investigational indications."}
{"id":"CHEMBL23013","canonicalSmiles":"N=C(N)c1ccc(OCCCOc2ccc(C(=N)N)cc2)cc1","inchiKey":"WTFXJFJYEJZMFO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PROPAMIDINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["M&B 782 [AS ISETHIONATE]","Propamidine"],"crossReferences":{"PubChem":["144206602"],"Wikipedia":["Propamidine"],"drugbank":["DB13296"],"chEBI":["87462"]},"childChemblIds":["CHEMBL3216426"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL249973","canonicalSmiles":"O=C(O)Cn1c(C(=O)Nc2nc(-c3ccccc3Cl)cs2)cc2ccccc21","inchiKey":"ILNRQFBVVQUOLP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LINTITRIPT","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Lintitript","SR-27897"],"crossReferences":{"PubChem":["144206134","170466345","50112865"],"drugbank":["DB04867"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL257704","canonicalSmiles":"CN(C)CCO/N=C(/C=C/c1ccc(O)cc1)c1ccccc1F","inchiKey":"VAIOZOCLKVMIMN-PRJWTAEASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EPLIVANSERIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Eplivanserin","SR-46349","SR46349"],"crossReferences":{"drugbank":["DB12177"]},"childChemblIds":["CHEMBL2103845"],"linkedTargets":{"rows":["ENSG00000102468"],"count":1},"linkedDiseases":{"rows":["EFO_0004698"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL259972","canonicalSmiles":"COc1ccc(-c2noc(CC(=O)O)c2-c2ccc(OC)cc2)cc1","inchiKey":"DJEIHHYCDCTAAH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MOFEZOLAC","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Mofezolac"],"crossReferences":{"PubChem":["144206111","50112817"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL268164","canonicalSmiles":"CCC1(C2=CCCCC2)C(=O)NC(=O)NC1=O","inchiKey":"WTYGAUXICFETTC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CYCLOBARBITAL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["Norway"],"classes":["Misuse"],"year":1980},"tradeNames":["Phanodorn"],"synonyms":["Cyclobarbital","Cyclobarbitone","Hexemal"],"crossReferences":{"Wikipedia":["Cyclobarbital"],"drugbank":["DB13737"]},"childChemblIds":["CHEMBL2106556"],"description":"Small molecule drug with a maximum clinical trial phase of IV. It was withdrawn in Norway  in 1980 due to Misuse."}
{"id":"CHEMBL286738","canonicalSmiles":"NS(=O)(=O)Oc1ccc2c3c(c(=O)oc2c1)CCCCC3","inchiKey":"DSLPMJSGSBLWRE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IROSUSTAT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["667 COUMATE","667-COUMATE","BN 83495","BN-83495","BN83495","Irosustat","STX 64","STX-64","STX64"],"crossReferences":{"drugbank":["DB02292"]},"linkedTargets":{"rows":["ENSG00000101846"],"count":1},"linkedDiseases":{"rows":["EFO_0003869","MONDO_0011962","MONDO_0007254","MONDO_0008315"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL293526","canonicalSmiles":"Cc1oc(-c2ccccc2)nc1CCOc1ccc(CC2C(=O)NOC2=O)cc1","inchiKey":"QBQLYIISSRXYKL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"REGLITAZAR","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["JT-501","JTT-501","JTT-501.BETA.","Reglitazar"],"crossReferences":{"drugbank":["DB04971"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL296939","canonicalSmiles":"O=C(COc1ccc(Cl)cc1C(=O)c1ccccc1)Nc1ccccc1","inchiKey":"DTGVSZSMDOMAEB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GF-128590","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GF-128590"],"crossReferences":{"drugbank":["DB07826"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL29757","canonicalSmiles":"N[C@H](CC(=O)O)C(=O)O","inchiKey":"CKLJMWTZIZZHCS-UWTATZPHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"D-ASPARTATE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["D-Aspartic Acid","D-aspartate"],"crossReferences":{"PubChem":["11110794","11113408","144204455","26751646"],"drugbank":["DB02655"],"chEBI":["17364"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL307679","canonicalSmiles":"Nc1ccn([C@@H]2O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]2O)c(=O)n1","inchiKey":"IERHLVCPSMICTF-XVFCMESISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"Cytidine 5'-Phosphate","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cytidine 5'-Phosphate","Cytidine-5'-Monophosphate"],"crossReferences":{"Wikipedia":["Cytidine_monophosphate"],"drugbank":["DB03403"],"chEBI":["17361"]},"childChemblIds":["CHEMBL1627075"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3085504","canonicalSmiles":"Cc1c(N)nc([C@H](CC(N)=O)NC[C@H](N)C(N)=O)nc1C(=O)N[C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@H](C(=O)NCCc1nc(-c2nc(C(=O)NCCC[S+](C)C)cs2)cs1)[C@@H](C)O)[C@@H](O[C@@H]1O[C@@H](CO)[C@@H](O)[C@H](O)[C@@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](OC(N)=O)[C@@H]1O)c1c[nH]cn1.O=S(=O)(O)O","inchiKey":"WUIABRMSWOKTOF-OYALTWQYSA-O","drugType":"Small molecule","blackBoxWarning":true,"name":"BLEOMYCIN SULFATE","yearOfFirstApproval":1973,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL403664","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Blenoxane","Bleomycin sulfate"],"synonyms":["Bleomycin sulfate","Bleomycin sulphate","Bleomycini sulfas","Bleomycins sulfate","Blexane"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1973 and has 5 approved and 27 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL308954","canonicalSmiles":"Cc1cc(C#N)cc(C)c1Oc1nc(Nc2ccc(C#N)cc2)nc(N)c1Br","inchiKey":"PYGWGZALEOIKDF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETRAVIRINE","yearOfFirstApproval":2008,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Intelence"],"synonyms":["Etravirine","R-165335","R165335","TMC 125","TMC-125","TMC125"],"crossReferences":{"DailyMed":["etravirine"],"Wikipedia":["Etravirine"],"drugbank":["DB06414"],"chEBI":["63589"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2008 and has 3 approved and 3 investigational indications."}
{"id":"CHEMBL327715","canonicalSmiles":"N=C(N)c1ccc2[nH]c(-c3cccc(-c4ccccc4)c3O)nc2c1","inchiKey":"LMGQGPVCSYOMNS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL327715","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01725"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3544986","canonicalSmiles":"CCC[C@H](N[C@@H](C)C(=O)N1[C@H](C(=O)O)C[C@@H]2CCCC[C@@H]21)C(=O)OCC.N=C(N)NCCC[C@H](N)C(=O)O","inchiKey":"RYCSJJXKEWBUTI-YDYAIEMNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PERINDOPRIL ARGININE","yearOfFirstApproval":2015,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1581","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Perindopril arginine"],"crossReferences":{"DailyMed":["perindopril%20arginine"],"chEBI":["77655"]},"linkedTargets":{"rows":["ENSG00000159640"],"count":1},"linkedDiseases":{"rows":["EFO_0001645","EFO_0000612","EFO_0000537"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2015 and has 3 approved indications."}
{"id":"CHEMBL3545036","canonicalSmiles":"Cc1cc(C)c(N)c(C#Cc2cccc(F)c2)n1","inchiKey":"MEDCLNYIYBERKO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RASEGLURANT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ADX-10059","ADX10059","Adx-10059","Adx10059","Raseglurant"],"childChemblIds":["CHEMBL3894333"],"linkedTargets":{"rows":["ENSG00000168959"],"count":1},"linkedDiseases":{"rows":["EFO_0003948","MONDO_0005277"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3545104","drugType":"Protein","blackBoxWarning":false,"name":"MODIMELANOTIDE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ABT-719","Ap-214","Ap214","Modimelanotide","ZP-1480","ZP1480"],"linkedTargets":{"rows":["ENSG00000124089","ENSG00000258839"],"count":2},"linkedDiseases":{"rows":["HP_0001919","EFO_0009833","EFO_0001666"],"count":3},"description":"Protein drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3545147","drugType":"Small molecule","blackBoxWarning":false,"name":"IMD-2560","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Imd-2560"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545268","drugType":"Small molecule","blackBoxWarning":false,"name":"MLN3126","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Mln3126"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545307","canonicalSmiles":"Cc1ccc(C(=O)Nc2ccc(Oc3cc4cnn(C)c4cc3-c3cn[nH]c3)c(F)c2)c(=O)n1-c1ccc(F)cc1","inchiKey":"QHADVLVFMKEIIP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MERESTINIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LY-2801653","LY2801653","Ly-2801653","Merestinib"],"crossReferences":{"drugbank":["DB12381"]},"linkedTargets":{"rows":["ENSG00000105976"],"count":1},"linkedDiseases":{"rows":["EFO_0000311","EFO_0002618","MONDO_0003060","EFO_0000389","MONDO_0007254","EFO_1001469","MONDO_0024880","EFO_0003060","EFO_1001934","EFO_1001951"],"count":10},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 8 investigational indications."}
{"id":"CHEMBL3545359","drugType":"Small molecule","blackBoxWarning":false,"name":"ARRY-300","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Arry-300","MET-300"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545412","drugType":"Small molecule","blackBoxWarning":false,"name":"K-877","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["K-877"],"linkedTargets":{"rows":["ENSG00000186951"],"count":1},"linkedDiseases":{"rows":["EFO_0004211","EFO_0003095","MONDO_0021187","Orphanet_309005"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3545424","drugType":"Small molecule","blackBoxWarning":false,"name":"AZD-8186","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AZD8186","Azd 8186","Azd-8186"],"linkedTargets":{"rows":["ENSG00000171608","ENSG00000051382"],"count":2},"linkedDiseases":{"rows":["MONDO_0001056","MONDO_0007254","EFO_0000196","EFO_0000305","MONDO_0008315","EFO_0003060"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL354739","canonicalSmiles":"Cc1ccc(NNC(=O)[C@@H](O)[C@H](N)CC2CCCCC2)cc1","inchiKey":"IQMLIGOOOFEBAH-CVEARBPZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL354739","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03086"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL359788","canonicalSmiles":"O=C1N[C@@H](Cc2ccc(O)cc2)C(=O)N2CCC[C@@H]12","inchiKey":"LSGOTAXPWMCUCK-RYUDHWBXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL359788","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04520"],"chEBI":["6631"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL360520","canonicalSmiles":"NC(=O)c1nn(-c2ccc(S(N)(=O)=O)cc2)c2c1ccc1[nH]ncc12","inchiKey":"HGAKLLFPOGATII-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL360520","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08527"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3697617","canonicalSmiles":"Cc1cc(Oc2ncccc2C(F)(F)F)ccc1-c1c(C)c(=O)[nH]c(=O)n1C","inchiKey":"AKQXQLUNFKDZBN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TAVAPADON","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CVL-751","Cvl-751","PF-06649751","Pf-06649751","Tavapadon"],"crossReferences":{"drugbank":["DB14899"]},"linkedTargets":{"rows":["ENSG00000184845","ENSG00000169676"],"count":2},"linkedDiseases":{"rows":["MONDO_0005180"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL3707266","canonicalSmiles":"CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n1C1CCCC1.O=C(O)CCC(=O)O","inchiKey":"NHANOMFABJQAAH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RIBOCICLIB SUCCINATE","yearOfFirstApproval":2017,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL3545110","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Kisqali"],"synonyms":["LEE-011-BBA","LEE011-BBA","Ribociclib succinate"],"crossReferences":{"DailyMed":["ribociclib%20succinate"]},"linkedTargets":{"rows":["ENSG00000135446","ENSG00000105810"],"count":2},"linkedDiseases":{"rows":["EFO_0000616","MONDO_0007254","EFO_0000305"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2017 and has 3 approved indications."}
{"id":"CHEMBL3707282","canonicalSmiles":"O=C([O-])c1cc(=O)[nH]c(=O)[nH]1.O=C([O-])c1cc(=O)[nH]c(=O)[nH]1.[Mg+2]","inchiKey":"QWLHYYKDLOVBNV-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"MAGNESIUM OROTATE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Magnerot classic"],"synonyms":["Magnesium orotate","Orotate magnesium","Orotic acid, magnesium salt"],"crossReferences":{"DrugCentral":["4594"],"drugbank":["DB13786"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL3707387","canonicalSmiles":"O.O=O.[O-][Cl+][O-].[O-][Cl+][O-].[O-][Cl+][O-].[O-][Cl+][O-]","inchiKey":"VOWOEBADKMXUBU-UHFFFAOYSA-J","drugType":"Small molecule","blackBoxWarning":false,"name":"TETRACHLORODECAOXIDE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL4299960","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ancloximex","Animexan","DAC N-055","Dac n-055","Dermazoon","Desopur","Immunokine","Macrokine","Oxoferin","Oxomexan","Oxovasin","Oxovir","Oxoviron","Tetrachlorodecaoxide","WF-10"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL391087","canonicalSmiles":"CCCOc1ccc(-c2csc(-c3ccccc3Cl)c2CC(=O)NC(=N)N)cc1","inchiKey":"VZSMTBLDWPKVRW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL391087","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07089"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3928407","canonicalSmiles":"N#Cc1c(N)nc(N)nc1N[C@H](c1nc2c(F)ccc(Cl)c2c(=O)n1-c1cccnc1)C1CC1","inchiKey":"XDSXYMOZKDUASY-INIZCTEOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GS-9901","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Gs 9901","Gs-9901"],"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3989693","canonicalSmiles":"CC(C)(C)NC[C@H](O)c1ccc(O)c(CO)c1.CC(C)(C)NC[C@H](O)c1ccc(O)c(CO)c1.O=C(O)C(O)C(O)C(=O)O","inchiKey":"VNVNZKCCDVFGAP-NMFAMCKASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LEVALBUTEROL TARTRATE","yearOfFirstApproval":2005,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1002","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Xopenex","Xopenex hfa"],"synonyms":["Levalbuterol tartrate","Levosalbutamol tartrate"],"crossReferences":{"DailyMed":["levalbuterol%20tartrate"]},"linkedTargets":{"rows":["ENSG00000169252"],"count":1},"linkedDiseases":{"rows":["MONDO_0004979","HP_0025428"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2005 and has 2 investigational indications."}
{"id":"CHEMBL3989759","canonicalSmiles":"CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2c-1nc1cc(F)c(C)c3c1c2[C@@H](N)CC3.CS(=O)(=O)O.O.O","inchiKey":"FXQZOHBMBQTBMJ-MWPGLPCQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EXATECAN MESYLATE","maximumClinicalTrialPhase":3,"parentId":"CHEMBL1614650","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DX-8951F","Exatecan mesilate dihydrate","Exatecan mesilate hydrate","Exatecan mesylate","Exatecan methanesulfonate dihydrate"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 15 investigational indications."}
{"id":"CHEMBL3989908","canonicalSmiles":"CC(C)(O)CNc1nc(Nc2ccnc(C(F)(F)F)c2)nc(-c2cccc(C(F)(F)F)n2)n1","inchiKey":"DYLUUSLLRIQKOE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"ENASIDENIB","yearOfFirstApproval":2017,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["AG-221","Ag 221","CC-90007 Free Base","Enasidenib"],"crossReferences":{"DailyMed":["enasidenib%20mesylate"],"drugbank":["DB13874"]},"childChemblIds":["CHEMBL3989931"],"linkedTargets":{"rows":["ENSG00000182054"],"count":1},"linkedDiseases":{"rows":["EFO_0000565","EFO_0000616","EFO_0000198","EFO_1001779","MONDO_0004600","EFO_0001421","EFO_0000222","EFO_0001378","MONDO_0044881","EFO_0000311"],"count":10},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2017 and has 3 approved and 7 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL3989951","canonicalSmiles":"O[C@H](C[C@H]1c2c(F)cccc2-c2cncn21)[C@H]1CC[C@H](O)CC1","inchiKey":"YGACXVRLDHEXKY-WXRXAMBDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NAVOXIMOD","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GDC-0919","IDO-IN-7","NLG-919","NLG919","Navoximod","RG-6078","RG6078","RO-7077339","RO7077339","RO7077339-001"],"crossReferences":{"drugbank":["DB15439"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3990026","drugType":"Enzyme","blackBoxWarning":false,"name":"ELAPEGADEMASE","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Revcovi"],"synonyms":["EZN-2279","Elapegademase","Elapegademase-lvlr"],"crossReferences":{"DailyMed":["elapegademase-lvlr"]},"description":"Enzyme drug with a maximum clinical trial phase of IV that was first approved in 2018 and is indicated for severe combined immunodeficiency."}
{"id":"CHEMBL406381","canonicalSmiles":"CCCNC(=O)Nc1ccc(Oc2ncnc3cc(OC)c(OC)cc23)cc1Cl","inchiKey":"VPBYZLCHOKSGRX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"KRN-633","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["K00589A","KRN-633","KRN633","Krn-633"],"crossReferences":{"PubChem":["174006598"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL412989","canonicalSmiles":"Cc1cn([C@H]2C[C@H](O)[C@@H](COP(=O)(O)OP(=O)(O)O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)O2)c(=O)[nH]c1=O","inchiKey":"YSYKRGRSMLTJNL-URARBOGNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL412989","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"Wikipedia":["Thymidine_diphosphate_glucose"],"drugbank":["DB03751"],"chEBI":["15700"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL415284","canonicalSmiles":"C=CCN1CC[C@]23c4c5ccc(O)c4O[C@H]2[C@@H](O)C=C[C@H]3[C@H]1C5","inchiKey":"UIQMVEYFGZJHCZ-SSTWWWIQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NALORPHINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Nalorphine","Nalorphine serb"],"crossReferences":{"PubChem":["50113068"],"Wikipedia":["Nalorphine"],"drugbank":["DB11490"],"chEBI":["7458"]},"childChemblIds":["CHEMBL1908349"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4297354","canonicalSmiles":"Cc1nc(C)c(-c2ccc(C3CCC(CC(=O)O)CC3)cc2)nc1C(N)=O","inchiKey":"YXFNPRHZMOGREC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZD-7687","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AZD7687","Azd 7687","Azd-7687","Azd7687"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297379","canonicalSmiles":"C[C@]12CC[C@@H]3[C@H]4CCC(=O)C=C4CC[C@H]3[C@@H]1C[C@H]1O[C@@H](c3ccco3)O[C@]12C(=O)C[18F]","inchiKey":"VJKRBRUNEOHPBS-JQKUZGBFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLUOROFURANYLNORPROGESTERONE F-18","maximumClinicalTrialPhase":1,"parentId":"CHEMBL378031","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(18f)ffnp","18f-ffnp","F18-ffnp","Ffnp f-18","Fluorofuranylnorprogesterone f-18"],"crossReferences":{"drugbank":["DB15282"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4297436","canonicalSmiles":"Cc1nc(-c2cccnc2)sc1C(=O)Nc1ccccc1-c1cn2c(CN3CCOCC3)csc2n1","inchiKey":"LAMQVIQMVKWXOC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SRT-2104","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SRT2104","Srt-2104","Srt2104"],"crossReferences":{"drugbank":["DB12186"]},"linkedTargets":{"rows":["ENSG00000096717"],"count":1},"linkedDiseases":{"rows":["HP_0100806","EFO_0000729","EFO_0009851","EFO_0000676","EFO_1000096","EFO_0000341","MONDO_0005148"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL4297450","canonicalSmiles":"COc1cc(CO)ccc1O","inchiKey":"ZENOXNGFMSCLLL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VANILLYL ALCOHOL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["FEMA NO. 3737","NSC-3993","V-0018","V0018","Vanillic alcohol","Vanillyl alcohol"],"crossReferences":{"drugbank":["DB12087"]},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297452","canonicalSmiles":"C[N+](C)(C)CCO.[O-]c1ccc(Cc2cc3cccccc-3c2)cc1[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O","inchiKey":"UKOOBSDARBTSHN-NGOMLPPMSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"YM-543","maximumClinicalTrialPhase":2,"parentId":"CHEMBL2397450","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ASP-543","YM 543","YM543","Ym-543","Ym543"],"linkedTargets":{"rows":["ENSG00000140675"],"count":1},"linkedDiseases":{"rows":["MONDO_0005148"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297549","drugType":"Enzyme","blackBoxWarning":false,"name":"HUMAN C1-ESTERASE INHIBITOR","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Berinert","C1-inhibitor, plasma derived","Cinryze","Human c1-esterase inhibitor","RVG-19303"],"linkedTargets":{"rows":["ENSG00000164344","ENSG00000182326","ENSG00000088926","ENSG00000131187"],"count":4},"linkedDiseases":{"rows":["EFO_0003884","EFO_0004256","EFO_0005532","EFO_1002048","Orphanet_91378"],"count":5},"description":"Enzyme drug with a maximum clinical trial phase of IV (across all indications) and is indicated for hereditary angioedema and has 4 investigational indications."}
{"id":"CHEMBL4297568","drugType":"Unknown","blackBoxWarning":false,"name":"BMS-986156","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bms-986156"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297724","drugType":"Oligosaccharide","blackBoxWarning":false,"name":"CERTOPARIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Certoparin"],"description":"Oligosaccharide drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4297758","drugType":"Unknown","blackBoxWarning":false,"name":"GDC-0927","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GDC-0927","Gdc-0927","RG-6047"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297915","canonicalSmiles":"Cc1ccc(S(=O)(=O)NO)o1","inchiKey":"LIXKIXWSKOENAB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CIMLANOD","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BMS-986231","Bms-986231","CXL-1427","Cimlanod","Cxl-1427"],"crossReferences":{"drugbank":["DB14983"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4298061","drugType":"Unknown","blackBoxWarning":false,"name":"LEXAPTEPID PEGOL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Lexaptepid pegol","NOX-H94","Nox-h94"],"description":"Unknown drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4298064","drugType":"Small molecule","blackBoxWarning":false,"name":"BERDAZIMER SODIUM","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Berdazimer sodium","NVN-1000","NVN1000","Nvn1000","Sb208"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL430488","canonicalSmiles":"COc1ccc2c(c1)N(C(=O)OC(C)C)[C@@H](CSC)C(=S)N2","inchiKey":"GWKIPRVERALPRD-ZDUSSCGKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TALVIRALINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["HBY 097","HBY-097","Hby 097","Talviraline"],"crossReferences":{"drugbank":["DB07885"]},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL44426","canonicalSmiles":"Cc1c(-c2ccc(O)cc2)n(Cc2ccc(OCCN3CCCCC3)cc2)c2ccc(O)cc12","inchiKey":"JICOGKJOQXTAIP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PIPENDOXIFENE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ERA-923","Era-923","Pipendoxifene"],"crossReferences":{"drugbank":["DB05414"]},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4540843","canonicalSmiles":"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)N)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O","inchiKey":"HFDKKNHCYWNNNQ-YOGANYHLSA-N","drugType":"Protein","blackBoxWarning":false,"name":"PANCREATIC POLYPEPTIDE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Human pancreatic polypeptide","Pancreatic hormone iii","Pancreatic polypeptide","Pancreatic polypeptide (human)","Pancreatic polypeptide human"],"description":"Protein drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4594330","drugType":"Antibody","blackBoxWarning":false,"name":"DAXDILIMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Daxdilimab","MEDI-7734","MEDI7734","Medi 7734","Medi7734","VIB7734","Vib-7734","Vib7734"],"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4594393","canonicalSmiles":"O=C([O-])CCCO.O=C([O-])CCCO.[Ca+2]","inchiKey":"AZRRVLSHRWGNRS-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"CALCIUM OXYBATE","yearOfFirstApproval":2020,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1342","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Calcium oxybate","Oxybate calcium"],"crossReferences":{"DailyMed":["calcium%20oxybate"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2020."}
{"id":"CHEMBL460282","canonicalSmiles":"CS(=O)(=O)OC[C@@H](OS(C)(=O)=O)[C@@H](O)[C@H](O)[C@@H](COS(C)(=O)=O)OS(C)(=O)=O","inchiKey":"UUVIQYKKKBJYJT-ZYUZMQFOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MANNOSULFAN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Mannosulfan","R-52"],"crossReferences":{"drugbank":["DB13334"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4650293","drugType":"Antibody","blackBoxWarning":false,"name":"APRUTUMAB IXADOTIN","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Aprutumab ixadotin","BAY 1187982","BAY-1187982","BAY1187982","Bay1187982"],"linkedTargets":{"rows":["ENSG00000261456","ENSG00000066468","ENSG00000188229","ENSG00000104833","ENSG00000137267","ENSG00000258947","ENSG00000101162","ENSG00000196230","ENSG00000137285","ENSG00000176014"],"count":10},"linkedDiseases":{"rows":["EFO_0000311"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4651038","drugType":"Protein","blackBoxWarning":false,"name":"PP-F11N LUTETIUM","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"childChemblIds":["CHEMBL4650306"],"description":"Protein drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL47072","canonicalSmiles":"CCC(=O)C1(c2cccc(O)c2)CCN(C)CC1","inchiKey":"ALFGKMXHOUSVAD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"KETOBEMIDONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["A 21 lundbeck","Cetobemidone","Ciba 7115","Cliradon","Cliradone","Cymidon","IDS-NK-001","IDS-NK-001(SECT.3)","Ketobemidone","Ketodur","Ketogan","Ketorax","NSC-117863"],"crossReferences":{"Wikipedia":["Ketobemidone"],"drugbank":["DB06738"],"chEBI":["6125"]},"childChemblIds":["CHEMBL259124"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL472193","canonicalSmiles":"O=C(Nc1cccc(C(F)(F)F)c1)Nc1ncc(CCNc2ncnc3ccsc23)s1","inchiKey":"JJHXPDTVQKWKHA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL472193","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07360"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4802159","canonicalSmiles":"N#Cc1ccc(N2C[C@@H](C(F)(F)F)C[C@@H](N)C2)c2cccnc12","inchiKey":"BJXYHBKEQFQVES-NWDGAFQWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ENPATORAN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Enpatoran","M-5049","M5049"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4802172","drugType":"Antibody","blackBoxWarning":false,"name":"EZABENLIMAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BI-754091","Ezabenlimab"],"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL500576","canonicalSmiles":"Oc1cccc(-c2c3nc(c(-c4cccc(O)c4)c4ccc([nH]4)c(-c4cccc(O)c4)c4nc(c(-c5cccc(O)c5)c5ccc2[nH]5)CC4)C=C3)c1","inchiKey":"LYPFDBRUNKHDGX-LWQDQPMZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL500576","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144206512","144206848"],"drugbank":["DB11630"],"chEBI":["9437"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL501849","canonicalSmiles":"COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)NS(=O)(=O)C6CC6)C[C@H]5/C=C\\CCCCN(C)C(=O)[C@@H]4C3)cc(-c3nc(C(C)C)cs3)nc2c1C","inchiKey":"JTZZSQYMACOLNN-VDWJNHBNSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"SIMEPREVIR","yearOfFirstApproval":2013,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Olysio"],"synonyms":["Simeprevir","TMC 435","TMC 435350","TMC-435","TMC-435350","TMC435350","Tmc435"],"crossReferences":{"drugbank":["DB06290"]},"childChemblIds":["CHEMBL3137358"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2013 and is indicated for viral disease and chronic hepatitis c virus infection and has 2 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL512172","canonicalSmiles":"Cc1cc(C)cc(Nc2nccc(-c3nc(C)c(C(=O)N[C@@H](C)CO)s3)n2)c1","inchiKey":"PEGXADGTBNRSGV-ZDUSSCGKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL512172","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07194"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL513922","canonicalSmiles":"CCN(Cc1ccccc1)C(=O)Cn1c(=O)n(C)c2cnc(-c3ccccc3)nc21","inchiKey":"NBMBIEOUVBHEBM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EMAPUNIL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AC-5216","Emapunil","XBD-173","XBD173"],"crossReferences":{"drugbank":["DB12666"]},"childChemblIds":["CHEMBL2206281"],"linkedTargets":{"rows":["ENSG00000100300"],"count":1},"linkedDiseases":{"rows":["EFO_0005230"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL519260","canonicalSmiles":"CCNC(=O)/C=C(C)/C=C/C=C(C)/C=C/c1c(C)cc(OC)c(C)c1C","inchiKey":"IYIYMCASGKQOCZ-DJRRULDNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MOTRETINIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Tasmaderm"],"synonyms":["Motretinide","NSC-351523","RO 11-1430","RO-11-1430"],"crossReferences":{"drugbank":["DB13368"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL527","canonicalSmiles":"CN1C(C(=O)Nc2ccccn2)=C(O)c2ccccc2S1(=O)=O","inchiKey":"QYSPLQLAKJAUJT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"PIROXICAM","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Brexidol","Feldene","Feldene 20","Feldene p","Flamatrol","Kentene","Larapam","Piroflam 10","Piroflam 20","Piroxicam","Pirozip 10","Pirozip 20"],"synonyms":["CP-16,171","CP-16171","NSC-666076","Piroxicam"],"crossReferences":{"DailyMed":["piroxicam"],"PubChem":["11111641","11111642","11113322","124881135","144203782","144207349","170464817","26746904","26751443","50085963","50103896","511550","856007","859011"],"Wikipedia":["Piroxicam"],"drugbank":["DB00554"],"chEBI":["8249"]},"childChemblIds":["CHEMBL2106953","CHEMBL1418195"],"linkedTargets":{"rows":["ENSG00000073756","ENSG00000095303"],"count":2},"linkedDiseases":{"rows":["HP_0002829","EFO_1001412","EFO_0000685","EFO_1001896","HP_0003326","EFO_0004616","HP_0100607","MONDO_0005178","EFO_0005752","EFO_0005755","EFO_0003843","EFO_0000537"],"count":12},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1982 and has 6 approved and 3 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL53418","canonicalSmiles":"O=C1c2cccc(O)c2C(=O)c2c(O)cccc21","inchiKey":"QBPFLULOKWLNNW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DANTHRON","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"],"classes":["Carcinogenicity"]},"tradeNames":["Dorbane","Istizin"],"synonyms":["Chrysazin","Danthron","Dantron","NSC-38626","NSC-646568","Pilules vinchy n.f."],"crossReferences":{"PubChem":["144204673","144208184","170465532","17389963","26747347","73151","8139970"],"Wikipedia":["Dantron"],"drugbank":["DB04816"],"chEBI":["3682"]},"linkedTargets":{"rows":["ENSG00000186350"],"count":1},"linkedDiseases":{"rows":["HP_0002019"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for constipation. It was withdrawn in United States due to Carcinogenicity."}
{"id":"CHEMBL563327","canonicalSmiles":"CCNC(=O)c1cc2c(-c3cc(OCCN4CCCC4)c(Cl)cc3Cl)nc(N)nc2s1","inchiKey":"WJUNQSYQHHIVFX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL563327","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06969"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL58510","canonicalSmiles":"CCN(CC)CCCC(C)Nc1ccnc2cc(Cl)ccc12.O=P(O)(O)O.O=P(O)(O)O","inchiKey":"QKICWELGRMTQCR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHLOROQUINE PHOSPHATE","yearOfFirstApproval":1949,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL76","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aralen","Avloclor","Chloroquine phosphate","Malarivon"],"synonyms":["Arechin","Chloroquine Diphosphate","Chloroquine Phosphate","Chloroquine diphosphate","Chloroquine phosphate","Chloroquini phosphas","Malaquin","NSC-14050","Resochin","SN-7618","WR-1522"],"crossReferences":{"DailyMed":["chloroquine%20phosphate"],"PubChem":["144203666","144210036","170464753","26747477","26747478","50106055"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1949 and is indicated for malaria and has 7 investigational indications."}
{"id":"CHEMBL586701","canonicalSmiles":"Cc1ccc(C2Sc3ccccc3N=C3C2=C(O)c2ccccc23)cc1","inchiKey":"SFUWDBKYNKBXQU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ZSTK-474","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GNF-PF-5468","ZSTK-474","Zstk-474","Zstk474"],"linkedTargets":{"rows":["ENSG00000145675","ENSG00000171608","ENSG00000105647","ENSG00000141506","ENSG00000051382","ENSG00000121879","ENSG00000105851","ENSG00000117461"],"count":8},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL65543","canonicalSmiles":"CC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O","inchiKey":"CAHKINHBCWCHCF-JTQLQIEISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ACETYL TYROSINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Acetyl Tyrosine"],"crossReferences":{"PubChem":["170465742","29215325"],"drugbank":["DB11102"],"chEBI":["21563"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL83527","canonicalSmiles":"COc1cc(/C=C/c2ccc(O)cc2)cc(OC)c1","inchiKey":"VLEUZFDZJKSGMX-ONEGZZNKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PTEROSTILBENE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["4-(3,5-Dimethoxystyryl)Phenol","Pterostilben","Pterostilbene","Pterostilbene, (e)-","Trans-pterostilbene"],"crossReferences":{"PubChem":["26657958","26719768"],"Wikipedia":["Pterostilbene"],"chEBI":["8630"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
